InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,591.60
(
-0.10%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.15
(
-0.40%
)
Bitcoin
64,234.51
(
1.69%
)
Post# of 642339
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1247
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Friday, 04/26/2024 3:42:25 PM

Friday, April 26, 2024 3:42:25 PM

Post# of 642339
NRXP -MC $35 m - 2x Phase 3 results imminent expected during this month , a potential 10 bagger here with positive data readouts

Upcoming milestones expected during Q2:

Release of top-line data from its trial of NRX-101 in Treatment Resistant Suicidal Bipolar Depression
Release of top-line data from Northwestern University's Department of Defense funded trial of the main component of NRX-101 in Chronic Pain
NDA filing for IV Ketamine for treatment of Suicidal Depression
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up